A detailed history of Valeo Financial Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 5,133 shares of EW stock, worth $336,108. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,133
Previous 4,779 7.41%
Holding current value
$336,108
Previous $456,000 3.95%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$84.3 - $94.31 $29,842 - $33,385
354 Added 7.41%
5,133 $474,000
Q1 2024

Apr 25, 2024

BUY
$72.54 - $95.56 $1,160 - $1,528
16 Added 0.34%
4,779 $456,000
Q1 2024

Apr 19, 2024

SELL
$72.54 - $95.56 $25,243 - $33,254
-348 Reduced 6.81%
4,763 $455,000
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $122,062 - $153,809
1,978 Added 63.13%
5,111 $389,000
Q3 2023

Oct 19, 2023

SELL
$69.28 - $93.38 $125,951 - $169,764
-1,818 Reduced 36.72%
3,133 $217,000
Q2 2023

Jul 14, 2023

BUY
$81.41 - $94.33 $45,752 - $53,013
562 Added 12.8%
4,951 $467,000
Q1 2023

Apr 17, 2023

BUY
$74.26 - $84.51 $116,216 - $132,258
1,565 Added 55.42%
4,389 $363,000
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $192,879 - $246,930
2,824 New
2,824 $210,000
Q2 2021

Jul 22, 2021

SELL
$83.84 - $104.76 $81,240 - $101,512
-969 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $3,226 - $4,105
-45 Reduced 4.44%
969 $88,000
Q3 2020

Oct 28, 2020

SELL
$67.19 - $87.44 $37,492 - $48,791
-558 Reduced 35.5%
1,014 $81,000
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $60,071 - $80,335
1,044 Added 197.73%
1,572 $109,000
Q1 2020

Apr 13, 2020

BUY
$52.41 - $81.0 $2,987 - $4,617
57 Added 12.1%
528 $113,000
Q4 2019

Jan 24, 2020

BUY
$71.7 - $82.09 $5,019 - $5,746
70 Added 17.46%
471 $110,000
Q3 2019

Oct 15, 2019

SELL
$61.55 - $75.43 $307 - $377
-5 Reduced 1.23%
401 $88,000
Q2 2019

Jul 10, 2019

SELL
$55.74 - $64.41 $3,511 - $4,057
-63 Reduced 13.43%
406 $75,000
Q1 2019

Apr 12, 2019

BUY
$47.89 - $64.05 $766 - $1,024
16 Added 3.53%
469 $90,000
Q4 2018

Jan 30, 2019

BUY
$46.41 - $56.94 $371 - $455
8 Added 1.8%
453 $69,000
Q3 2018

Nov 01, 2018

BUY
$45.7 - $58.03 $822 - $1,044
18 Added 4.22%
445 $65,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $1,740 - $2,103
-41 Reduced 8.76%
427 $59,000
Q4 2017

Feb 09, 2018

BUY
$33.79 - $39.39 $7,467 - $8,705
221 Added 89.47%
468 $53,000
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $8,963 - $9,591
247
247 $27,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.